Abstract-Distribution microgrids are being challenged by reverse power flows and voltage fluctuations due to renewable generation, demand response, and electric vehicles. Advances in photovoltaic (PV) inverters offer new opportunities for reactive power management provided PV owners have the right investment incentives. In this context, reactive power compensation is considered here as an ancillary service. Accounting for the increasing time-variability of distributed generation and demand, a stochastic reactive power compensation scheme is developed. Given uncertain active power injections, an online reactive control scheme is devised. This scheme is distribution-free and relies solely on power injection data. Reactive injections are updated using the Lagrange multipliers of a second-order cone program. Numerical tests on an industrial 47-bus microgrid and the residential IEEE 123-bus feeder corroborate the reactive power management efficiency of the novel stochastic scheme over its deterministic alternative, as well as its capability to track variations in solar generation and household demand.
This paper analyzes the market-clearing formulation with stochastic security developed in its companion paper through two case studies solved using mixed-integer linear programming techniques. The generation and reserve schedules as well as the nodal prices of energy and security are assessed under various conditions such as a) line flow limits; b) when nonspinning reserve is excluded from the formulation; c) demandside valuation of energy not served; d) generator ramping limits; and, e) the set of pre-selected contingencies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.